Advertisement

Topics

Wuxi Syder Bio-products Co.,Ltd. Company Profile

02:53 EDT 21st June 2018 | BioPortfolio

Wuxi Syder Bio-Products Co., LTD is a specialized one mainly producing Heat Stable a-Amylase. They devote themselves to making a breakthough in fermentation level, products quality and using effects. In the aspects of managerment, they accept ISO-9002 qua

Location

No.734 Life Tower No.78 Jie Fang Road West
Wuxi
Jiangsu
214043
China

Contact

Phone: 0510-2699868
Fax: 0510-5699968
Email: sales@syder.com


News Articles [244 Associated News Articles listed on BioPortfolio]

Adagene to Collaborate with WuXi Biologics for Antibody Manufacturing

Adagene, a Suzhou antibody discovery company, formed a strategic collaboration with WuXi Biologics giving WuXi responsibility for process development and manufacturing of Adagene products. Adagene has...

WuXi STA And Regulus To Collaborate On MicroRNA Development And Manufacturing

NewsThe agreement follows the recent opening of WuXi STA's oligonucleotide research and development laboratories in China and the United States.

WuXi STA And Regulus To Team Up On MicroRNA Development And Manufacturing

NewsThe agreement follows the recent opening of WuXi STA's oligonucleotide research and development laboratories in China and the United States.

WuXi Biologics to Build $20 Million ADC Facility in Wuxi City

WuXi Biologics has begun construction of a $20 million state-of-the-art integrated biologics conjugate R&D/CDMO center in Wuxi city, China. The company said the 6,000 square meter facility, which ...

WuXi AppTec Approved for $910 Million Shanghai IPO

WuXi AppTec announced a $910 million IPO on the Shanghai exchange for the company's core small-molecule CRO business. China regulators approved WuXi's prospectus in a short seven weeks, indicating tha...

WuXi AppTec IPOs in Shanghai Exchange

WuXi AppTec Co., Ltd. announced its initial public offering in Shanghai stock exchange for 104,198,600 shares of common stock at a price of $3.40 per share. WuXi’s stock price raised 43.98% to $...

WuXi Biologics kicks off $20m ADC build in China

WuXi Biologics has started building its antibody-drug conjugate (ADC) centre in Wuxi City, China, where it will offer biologics conjugate services for clients.

WuXi Biologics Invests $60 Million in Another New Plant -- In Singapore This Time

WuXi Biologics will spend $60 million to build a biologics CDMO plant in Singapore. The facility will be WuXi Biologics' tenth manufacturing plant globally and the third new facility it has announced ...

PubMed Articles [787 Associated PubMed Articles listed on BioPortfolio]

Pediatric Toxicology: Household Product Ingestions.

Nonpharmaceutical household products are the most common substances involved in exploratory ingestions in young children. Fortunately, most of these products are not toxic if ingested in small volumes...

Maternal air pollution exposure and preterm birth in Wuxi, China: Effect modification by maternal age.

Numerous studies have investigated prenatal air pollution and shown that air pollutants have adverse effect on birth outcomes. However, which trimester was the most sensitive and whether the effect wa...

The Use of Regulatory Power by U.S. State and Local Alcohol Control Agencies to Ban Problematic Products.

Alcohol is responsible for 4,300 deaths a year in the U.S. among persons under 21. Alcohol companies innovate rapidly and produce new products, some of which prove popular among young people. The 18 "...

Dietary Intake and Content of Cu, Mn, Fe, and Zn in Selected Cereal Products Marketed in Poland.

This paper aims to verify whether cereal products are a good source of Cu, Mn, Fe, and Zn in the diets of Poles. The study material comprised of 445 cereal products including baked goods, breakfast ce...

Modernizing Regulation of Cosmetic Products: Reintroduction of the Personal Care Products Safety Act.

Clinical Trials [933 Associated Clinical Trials listed on BioPortfolio]

Serological Screening of Gastric Cancer in Wuxi Region

The purpose of this study is to determine whether detection of pepsinogen Ⅰand Ⅱ combined with Helicobacter pylori antibody, so-called ABC method , is fit on gastric cancer screening i...

Gastrointestinal Toleration of Inulin Products

The intake of inulin products has been linked to multiple health benefits which has lead to inulin fortification in food products. The investigators hypothesis that doses of up to 10 gram...

Human Laboratory Study of Smokeless Tobacco Products

With the advent of restrictions on public smoking, the tobacco industry has introduced a variety of novel smokeless tobacco products (NSTP) to allow continued tobacco use. These products t...

Oat Products in the Treatment of Coeliac Disease in Children

In many Northern European countries oat-based products have been used in the dieto-therapy of coeliac disease for many years. The purpose of this study is to evaluate clinical tolerance a...

Safe Water Techniques in Kenya

Consumer preferences for POU technologies vary across consumers and products, and largely determine their adoption and subsequent usage. This is a marketing study that asks which products...

Companies [413 Associated Companies listed on BioPortfolio]

Wuxi syder Bio-products Co., Ltd

Wuxi syder Bio-products Co., Ltd is located at Xishan Economic & Technological Development Zone, Our main products are Syder Brand High Temperature α-amylase, Syder Brand High Conversion Efficien...

Wuxi Syder Bio-products Co.,Ltd.

Wuxi Syder Bio-Products Co., LTD is a specialized one mainly producing Heat Stable a-Amylase. They devote themselves to making a breakthough in fermentation level, products quality and using effects. ...

WuXi PharmaTech (Cayman) Inc.

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused co...

WuXi PharmaTech, Ltd.

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused com...

ABEC and WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover d...

More Information about "Wuxi Syder Bio-products Co.,Ltd." on BioPortfolio

We have published hundreds of Wuxi Syder Bio-products Co.,Ltd. news stories on BioPortfolio along with dozens of Wuxi Syder Bio-products Co.,Ltd. Clinical Trials and PubMed Articles about Wuxi Syder Bio-products Co.,Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Wuxi Syder Bio-products Co.,Ltd. Companies in our database. You can also find out about relevant Wuxi Syder Bio-products Co.,Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record